Highlights from the European Oncology Nursing Society (EONS) session by Paz Fernández-Ortega Ph.D, Nursing Research Coordinator at the Catalan Institute of Oncology in Barcelona, Spain

Paz Fernández is the Nursing Research Coordinator at the Catalan Institute of Oncology in Barcelona and since 2010, Associated Professor at the Faculty of Medicine and Health Sciences at the University of Barcelona, where she earned her Doctorate in Nursing Sciences and a Bachelor in Clinical Psychology. From 1999 to 2005, Paz has been a member on the Executive Board of EONS (European Oncology Nursing Society), and until 2001, a Board member of SEEO (Spanish Oncology Nursing Society). Paz belongs to the Node of Cancer at Joanna Briggs Institute and to the EANS (European Academy of Nursing Science) scholars group. Her area of expertise is symptoms management in cancer patients, chemoterapy and oral anticancer drugs. In 2014 she received the EONS Lifetime Achievement Award for her 30 years in oncology and professional contribution to the field of oncology nursing.
Experts
Paz Fernández Ortega
  • download Downloadable
    Resouces
  • clock 5 MIN
  • calendar Sep 2021
This educational programme is supported by an Independent Educational Grant from Bayer
Programme summary
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Eisai Europe Limited.

Meet the experts

Other programmes of interest

other Other

Episode

2

of 2

episode
Oncology 
Optimising samples for biomarker testing in lung, prostate and gastric cancer

Recommendations for best practice

Experts
Dr Alexander Wyatt, Prof. Frédéric Bibeau
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Aug 2024

Educational programme supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.
publication Publication
Oncology 
Advancing HCC management in Asia: insights from patients and HCPs

Paper published in Journal of Gastrointestinal Cancer

Experts
Prof. Chee-Kiat Tan
  • download Downloadable
    Resources
  • clock 15 MIN
  • calendar Jul 2024

This educational programme is supported by an Independent Educational Grant from Roche.
micro-learning Micro learning
Oncology Endocrinology Rare diseases 
Tools for optimising treatment & management of advanced NETs

Maximising outcomes for patients with advanced neuroendocrine tumours 

Experts
Prof. Emily Bergsland, Asst Prof. Louis de Mestier
Endorsed by
NANETS
Neuroendocrine Cancer UK
CommNETs
The Healing NET Foundation
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jul 2024

Educational programme supported by an Independent Educational Grant from Ipsen.
video Video
Oncology 
The evolving role of liquid biopsy in biomarker testing

Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer

Experts
Assoc. Prof. Umberto Malapelle
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jul 2024

Educational programme supported by an Independent Educational Grant from Bayer.
interactive-patient-case Interactive patient case
Oncology 
Advanced renal cell carcinoma: Managing a long-term durable response

Maximising outcomes for patients with advanced RCC 

Experts
Prof. Michael Staehler
Endorsed by
Urobel VZW | ASBL
  • clock MIN
  • calendar Jun 2024

Educational programme supported by an Independent Educational Grant from Eisai Europe Limited.
other Other

Episode

1

of 1

episode
Oncology 
Overcoming pre-analytical phase challenges in gastric, prostate and lung cancer

Medical experts make recommendations for best practice

Experts
Dr Alexander Wyatt, Prof. Frédéric Bibeau
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.